Evidence map›Paper›PMID 36402891›Full record

ArticleScientific reports2022

GediNET for discovering gene associations across diseases using knowledge based machine learning approach.

Emma Qumsiyeh, Louise Showe, Malik Yousef

Abstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Emma QumsiyehInformation Technology Engineering, Al-Quds University, Abu Dis, Palestine. emma.qumsiyeh@hotmail.com.
Louise ShoweThe Wistar Institute, Philadelphia, PA, 19104, USA.
Malik YousefDepartment of Information Systems, Zefat Academic College, 13206, Zefat, Israel. malik.yousef@gmail.com.

Funding

Tumor Microenvironment and MetastasisP30CA010815 · NCI · WISTAR INSTITUTE · PI Luis J Montaner · 1985 to 2026
$75.9M
Integration of Biomarker Signatures from Peripheral Blood for Diagnosis, Prognosis, Remission and Recurrence of Lung CancerU01CA200495 · NCI · WISTAR INSTITUTE · PI LIU, QIN, SHOWE, LOUISE C. · 2016 to 2021
$4.0M
NCI NIH HHS P30 CA010815NCI NIH HHS U01 CA200495
6 · The paper itself

Abstract

The most common approaches to discovering genes associated with specific diseases are based on machine learning and use a variety of feature selection techniques to identify significant genes that can serve as biomarkers for a given disease. More recently, the integration in this process of prior knowledge-based approaches has shown significant promise in the discovery of new biomarkers with potential translational applications. In this study, we developed a novel approach, GediNET, that integrates prior biological knowledge to gene Groups that are shown to be associated with a specific disease such as a cancer. The novelty of GediNET is that it then also allows the discovery of significant associations between that specific disease and other diseases. The initial step in this process involves the identification of gene Groups. The Groups are then subjected to a Scoring component to identify the top performing classification Groups. The top-ranked gene Groups are then used to train a Machine Learning Model. The process of Grouping, Scoring and Modelling (G-S-M) is used by GediNET to identify other diseases that are similarly associated with this signature. GediNET identifies these relationships through Disease-Disease Association (DDA) based machine learning. DDA explores novel associations between diseases and identifies relationships which could be used to further improve approaches to diagnosis, prognosis, and treatment. The GediNET KNIME workflow can be downloaded from: https://github.com/malikyousef/GediNET.git or https://kni.me/w/3kH1SQV_mMUsMTS .

Indexed as

Knowledge BasesMachine LearningBiomarkersProteomicsBiomarkers

Identifiers

PMID36402891
PMCPMC9675776

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.